Vinceti M, Rothman KJ, Bergomi M, Borciani N, Serra L, Vivoli G. Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Cancer Epidemiol Biomarkers Prev. 1998 Oct 1;7(10):853-6.
Vinceti M, Rothman KJ, Bergomi M, Borciani N, Serra L, Vivoli G. Reply to commentary on Excess melanoma incidence in a cohort exposed to high levels of environmental selenium. Cancer Epidemiol Biomarkers Prev. 1998 Oct;7:851-2.
Neighbors D. Clinical benefit endpoints in trials for the treatment of non-small cell lung cancer and hormone-refractory prostate cancer. Presented at the Investigator Meeting; 1998. San Diego, CA.
Poole C, Rothman KJ, Dreyer NA. Leukemia near Pilgrim nuclear-power plant, Massachusetts. Lancet. 1988 Dec 3;332(8623):1308. doi: 10.1016/S0140-6736(88)92915-7
Dreyer NA, Loughlin JE, Lanes SF, Rothman KJ. Mortality among employees of a nuclear power company. J Occup Environ Med. 1988 Jan 1;30(12):988-9.
Jick H, Porter J, Morrison AS, Rothman KJ. Lung cancer in young women. Arch Intern Med. 1979 Jul 1;139(7):745-6.
Jick H, Watkins RN, Hunter JR, Dinan BJ, Madsen S, Rothman KJ, Walker AM. Replacement estrogens and endometrial cancer. N Engl J Med. 1979 Jan 1;300(5):218-22.